Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$126,783,481
+$25,535,779 QoQ
Shares Held
136,654
-1.4% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#33
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAMCO INC /NY/ holds $406,272,438 across 24 Biotechnology names. ARGX ranks #2 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
1,989,386 | $139,316,701 | |
| 2 | ARGX |
Argenx SE
This page
|
136,654 | $126,783,481 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,253,120 | $32,856,806 | |
| 4 | ZLAB |
Zai Lab Ltd
|
1,623,694 | $30,850,186 | |
| 5 | MANE |
Veradermics, Inc
|
229,581 | $28,224,688 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
520,108 | $24,465,880 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
125,000 | $4,423,750 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,000 | $2,980,380 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,783,481 | 136,654 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $101,247,702 | 138,648 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $129,269,993 | 153,719 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $123,684,386 | 167,694 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $99,623,644 | 180,733 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,303,991 | 213,400 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $148,939,470 | 242,178 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $135,684,792 | 250,304 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $112,445,999 | 261,478 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $104,994,887 | 266,674 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $109,327,592 | 287,379 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $141,585,015 | 287,991 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $97,536,947 | 250,268 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $92,755,653 | 248,955 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $138,002,465 | 364,286 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $147,292,813 | 417,201 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $159,373,977 | 420,645 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $158,077,200 | 501,339 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $197,344,321 | 563,535 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $166,301,132 | 550,666 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $165,049,885 | 548,211 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $135,967,478 | 493,727 | Shares | Defined | 2021-05-19 | |
| 2020-12-31 | $109,518,527 | 372,398 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $77,638,714 | 295,744 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $60,052,173 | 266,626 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $28,490,037 | 216,276 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||